A series of novel fluorophenyl-substituted 1,2,4-triazole derivatives were synthesized and characterized via NMR spectroscopy. The synthetic pathway involved key transformations including hydrazinolysis, isocyanate coupling, and cyclization reactions. The structural elucidation confirmed the successful formation of target compounds through spectral analyses. The antimicrobial activity of the synthesized compounds was evaluated against Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis), Gram-negative bacteria (Escherichia coli, Salmonella typhimurium) and fungal strains (Candida spp.) using the Minimum Inhibitory Concentration (MIC) method. Among the tested derivatives, compounds 6a–6f exhibited significant antimicrobial potency, with MIC values as low as 6.25 µg/mL against E. coli and S. aureus. In contrast, earlier-stage intermediates (4a–5c) demonstrated moderate to weak activity, indicating that structural modifications such as fluorophenyl-triazole hybridization enhanced biological efficacy. To further analyze the structure-activity relationship, chemotype clustering was performed, categorizing the synthesized derivatives based on their core scaffolds and functional groups. This clustering approach provided insights into the impact of different substituents on antimicrobial efficacy, highlighting key structural features contributing to bioactivity. The most active compounds, 6a–6f, displayed promising antibacterial activity comparable to standard antibiotics (tetracycline and ampicillin) and exhibited moderate antifungal effects. These findings suggest that fluorophenyl-triazole hybrids are potential candidates for antimicrobial drug development. Further studies, including in vivo evaluations, mechanism of action investigations, and expanded chemotype clustering analyses, are warranted to explore their full therapeutic potential.
Uygun et al. (Wed,) studied this question.